Croatia

Reimbursed Care Access

Croatia classifies most classic psychedelic compounds as controlled substances under its Law on Combating Drug Abuse; possession of small amounts was decriminalized as a misdemeanour in 2013 but medical/therapeutic access is limited. The only psychedelic-derived medicine with an EU marketing authorisation (esketamine/Spravato) is authorised at the EU level and may be supplied in Croatia under usual pharmaceutical channels, while ketamine is available as an approved anaesthetic and is used off‑label in some private settings for psychiatric indications. Other compounds (psilocybin, MDMA, DMT, 5‑MeO‑DMT, ibogaine, ayahuasca, mescaline, 2C‑X) have no authorised medical use in routine care and are subject to national drug‑control measures except within approved research. [https://narodne-novine.nn.hr/clanci/sluzbeni/full/2001_12_107_1756.html|Narodne Novine — Law on Combating Drug Abuse] [https://www.ema.europa.eu/en/medicines/human/EPAR/spravato|EMA — Spravato EPAR]